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B I O P H Y S I C S
Structure and mechanism of bactericidal mammalian 
perforin-2, an ancient agent of innate immunity
Tao Ni1*, Fang Jiao2*, Xiulian Yu1,3*, Saša Aden4, Lucy Ginger1†, Sophie I. Williams1,5, 
Fangfang Bai6, Vojtěch Pražák1, Dimple Karia1, Phillip Stansfeld5, Peijun Zhang1, 
George Munson6, Gregor Anderluh4, Simon Scheuring2,7‡, Robert J. C. Gilbert1,3‡
Perforin-2 (MPEG1) is thought to enable the killing of invading microbes engulfed by macrophages and other 
phagocytes, forming pores in their membranes. Loss of perforin-2 renders individual phagocytes and whole 
organisms significantly more susceptible to bacterial pathogens. Here, we reveal the mechanism of perforin-2 
activation and activity using atomic structures of pre-pore and pore assemblies, high-speed atomic force micros-
copy, and functional assays. Perforin-2 forms a pre-pore assembly in which its pore-forming domain points in the 
opposite direction to its membrane-targeting domain. Acidification then triggers pore formation, via a 180° confor-
mational change. This novel and unexpected mechanism prevents premature bactericidal attack and may have 
played a key role in the evolution of all perforin family proteins.
INTRODUCTION
Mammalian innate immunity is mediated by a range of factors in-
cluding the membrane attack complex (MAC), which is deployed to 
kill invading microbes such as Neisseria species, while perforin-1 is 
used by cytotoxic lymphocytes to deliver granzymes into host cells 
targeted for destruction (1, 2). Both the MAC complex and perforin-1 
are known to form large -barrel pores using similar mechanisms 
(1–5). Perforin-2 (PFN2) has recently been identified as a novel and 
critically important component of innate immunity conserved through-
out the animal kingdom (6–9) and evolutionarily close to the last 
common ancestor of the MAC and perforin-1 (7, 10). PFN2 is con-
stitutively expressed in macrophages; however, its expression can 
be induced in many different cell types by interferons (, , and ), 
bacterial infection, and pathogen-associated molecular patterns such 
as lipopolysaccharide (LPS) (10–14). Knockdown or deletion of PFN2 
renders isolated cells and whole animals susceptible to infection, 
morbidity, and, in many cases, death (10, 12, 13). In human patients 
with pulmonary nontuberculous mycobacteria, four-point mutations 
of PFN2 have been identified (15), and macrophages expressing 
these mutant versions of PFN2 are unable to control Salmonella 
typhimurium or Staphylococcus aureus infection (15).
Because of the presence of a canonical MAC-perforin (MACPF) 
domain, PFN2 has been proposed to form functional pores in 
bacterial membranes, leading to bacterial death and control of in-
fection (10–13, 16). However, unlike MAC components and perforin-1, 
PFN2 is initially synthesized as a type I transmembrane protein and 
found associated with the membranes of intracellular vesicles in 
which its large ectodomain (consisting mainly of the MACPF do-
main and a unique P2 domain characteristic of PFN2) projects into 
the lumen. The PFN2 cytosolic tail, with a ubiquitin modification 
site, is then responsible for directing PFN2 to bacteria-encapsulating 
phagosomes (13) where it is thought to be further activated by pro-
teolytic cleavage from its transmembrane anchor (12). In this study, 
we provide a detailed framework for understanding the role of 
PFN2 in defense against intracellular bacteria, showing that it first 
assembles into a pre-pore state as a ring of 16 subunits, the pore- 
forming transmembrane hairpins (TMHs) of which point in the 
opposite direction to their membrane-binding domains. A complete 
(180°) reconfiguration of the MACPF and membrane-binding P2 
domains triggered by acidification then results in pore formation. 
The evolutionary closeness of PFN2 to the common origin of all 
MACPF/cholesterol-dependent cytolysin (CDC) proteins suggests 
that this previously unobserved mechanism of pre-pore–to–pore 
transition may have played an important role in the evolutionary 
adaptation of the entire family to which it belongs.
RESULTS
Cryo-EM structure of the PFN2 pre-pore oligomer
To characterize the basis for PFN2 activity, we have determined the 
molecular structure of its ectodomain in the context of a pre-pore 
assembly formed in solution at endosomal pH 5.5 (Fig. 1, A and B; 
fig. S1; and table S1). Most of the oligomers observed were full rings 
containing 16 subunits, with a very small percentage (<2%) of in-
complete rings (arcs) with similar curvature to the ring (fig. S1, 
A and B), as observed with other MACPF/CDC family proteins in-
cluding perforin-1 (1, 2, 4, 5). We determined the near-atomic reso-
lution structure of this pre-pore form at an overall resolution of 3.5 Å 
(fig. S1C), with local resolution varying from 3.3 to 4.75 Å (fig. S1D). 
The resolution of the peripheral P2 domain is relatively low in the 
cryo–electron microscopy (cryo-EM) structure, and in particular, 
an extended -hairpin region was not well resolved. However, by 
determining a structure of the P2 domain in isolation by x-ray crys-
tallography (at 2.05 Å resolution; Fig. 2, A and B, and table S2), we 
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were able to build an atomic model for the whole complex (Fig. 1, 
C and D) into the cryo-EM map (Fig. 1, A and B). This revealed the 
presence of the expected MACPF family domain at the protein’s N 
terminus, followed by an epidermal growth factor (EGF)–like repeat 
and the P2 domain and finally a C-terminal tail (CTT) not present 
in other MACPF/CDC family proteins (Fig. 1, E to G).
As observed in other MACPF/CDC proteins, such as the Apicom-
plexan perforin–like protein TgPLP1 (17) and the pneumolysin pre-
pore (18, 19), the MACPF domains make extensive complementary 
contacts with each other in the PFN2 pre-pore structure (Fig. 1H). 
However, the CTT region of PFN2 (A577-I642, colored orange in 
Fig. 1) threads back from the end of the globular region of the P2 
domain, passes down between the MACPF and P2 domains, and folds 
into a two-stranded  sheet on the top of the MACPF domain before 
terminating in an  helix. This packs the CTT’s  strands against the 
 hairpin of the P2 domain from an adjacent subunit to create a 
continuous four-stranded intermolecular  sheet (Fig. 1, D and I). 
The folding of the PFN2 polypeptide chain from one subunit onto 
the next generates an additional stable intersubunit interface (Fig. 1D) 
absent in other MACPF/CDC superfamily members.
The pre-pore of PFN2 has a distinctive hat-like appearance in 
profile (Fig. 1, A to D) with the MACPF and P2 domains arranged 
concentrically. The larger MACPF domain is located inside, and the 
smaller P2 domains toward the outside of the ring of subunits, 
linked via a truncated EGF-like domain (Fig. 1, E to G). The PFN2 
MACPF domain is closely related to the equivalent region of perforin-1, 
with two sets of transmembrane hairpin (TMH1 and TMH2)  helices 
prominently displayed available to form a  sheet traversing a targeted 
membrane on pore formation (Fig. 1, J and K). Like perforin-1, the 
TMH regions of PFN2 are similar to each other in length, though 
shorter (40 and 45 for TMH1 and TMH2 in PFN2 compared to 53 and 
57 residues in perforin-1, respectively). The MACPF domain also 
contains conserved glycosylation sites (Fig. 1J), in equivalent posi-
tions to those found in the MAC component C9 and perforin-1. 
Construction of a structure-based phylogenetic tree for the PFN2 
MACPF domain (fig. S2) places it at a position entirely consistent 
with sequence-based phylogenetic analyses, which indicated that 
perforin-1 derives from a PFN2 ancestral gene duplication (7, 9).
The  hairpin of the P2 domain directs  
membrane recognition
We determined structures of the P2 domain in isolation by x-ray 
crystallography in two crystal forms, with two crystallographically 
distinct copies in space group P21 at 2.05 Å and eight copies in space 
group P1 at 3.17 Å (table S2). In both crystal forms, the extended  
hairpin of the P2 domain could be unambiguously modeled and 
extends for 45 Å (Fig. 2, fig. S3, and table S2). The P2 domain has 
pseudo-threefold symmetry (Fig. 2, A and B, and fig. S3B) with a 
topological arrangement of constituent modules not previously observed 
(fig. S3A) distinct from the membrane-binding APC domains of 
Fig. 1. Cryo-EM structure of the PFN2 pre-pore oligomer. (A and B) Cryo-EM map of the mPFN2 pre-pore at 3.5 Å resolution as viewed from the top (A) and the side (B), 
color-coded by different domains (MACPF in blue, EGF in purple, P2 in green, and CTT in orange). (C and D) Top and side views of the atomic model of the mPFN2 pre-pore 
shown as ribbons; domains are colored as in (A). (E) Domain organization of the mPFN2: SP, signal peptide; TM, transmembrane helix; and Cyto, cytosolic tail. (F and 
G) Cryo-EM map of one subunit of the pre-pore colored as in (A). (H) The  sheet formed between MACPF domains marked with a dashed rectangular box. (I) Close-up 
view of the four-stranded  sheet formed between the CTT and the adjacent P2. (J and K) Ribbon representation of the pre-pore subunit as colored in (A); TMH-forming 
 helices are colored in red, and the conserved N-link glycans are colored in cyan.
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Apicomplexan perforin–like proteins (17). Each repeat contains three 
strands with a conserved interstrand disulfide bond [pairwise root 
mean square deviation (RMSD) = 0.76 to 1.00 Å calculated from the 
three repeats]. The first repeat is much more extended than the other 
two and gives rise to the long -hairpin projection, which is braced 
by two additional disulfide bonds, and enriched in positively charged 
residues along its length (fig. S3, B and C) and with mainly hydro-
phobic residues (LKIF) forming its tip (fig. S3B). Overlay of the cryo-EM 
and 10 crystallographically distinct copies of the isolated P2 domain 
structure (see above, Fig. 2C) indicates flexibility in the  hairpin. 
The pore-forming conformation of the P2 hairpin echoes the crystal 
structures (see below), whereas the pre-pore positioning of the hairpin 
is distorted away from its ensemble of resting (crystallographic) 
conformations (Fig. 2C). The rigidifying disulfide bonds and the 
hydrophobic residues in the P2 domain tip are highly conserved 
across species, although the identities of the residues along the  
hairpin mostly are not (fig. S4, dashed black box). The highly basic 
nature of this projection (fig. S3D) and functional analogy to other 
family members including TgPLP1, perforin-1, and the CDCs strongly 
suggest that the  hairpin will be involved in membrane targeting 
and binding by PFN2.
To test this hypothesis, we made use of liposome sedimentation 
experiments with the P2 domain alone (Fig. 2, D to F). Liposomes 
containing phosphatidylcholine (PC) and phosphatidylethanolamine 
(PE) showed no sedimentation of the P2 domain. When adding to 
these base lipids increasing concentrations of phosphatidylserine 
(PS) from 5 to 30%, the binding efficiency was gradually enhanced 
(Fig. 2D). Given that negatively charged lipids such as cardiolipin, 
Escherichia coli total lipid extracts, and LPS from E. coli and Salmonella 
enterica are characteristic of major bacterial membrane lipid species, 
we also tested and confirmed preferential binding of the P2 domain 
to these lipids (Fig. 2E). In contrast, the P2 domain showed almost 
no binding to liposomes containing sphingomyelin, which is a neutrally 
charged lipid found in animal cell membranes (Fig. 2E). Truncating 
the  hairpin (residues Y427-V452) within the P2 domain (P2hairpin 
mutant) abolished its binding to PS, cardiolipin, and E. coli lipids, 
confirming the role of this region in membrane binding by PFN2 
(Fig. 2F). Although the CTT domain contributes directly to the inter-
subunit contacts with the P2  hairpin and seems in the pre-pore 
assembly to be positioned such that it would lie along the top of the 
bilayer surface, truncation of the CTT domain (606-652aa) within 
the ectodomain of mPFN2 showed no effect on the protein’s lipid 
binding activity (fig. S3E). Thus, membrane binding seems to be 
conferred exclusively by the tip region of the P2 domain  hairpin.
Dynamics of PFN2 pre-pore assembly on membranes
PFN2 pre-pore oligomeric assemblies were studied further using high-
speed atomic force microscopy (HS-AFM) (Fig. 3). When PFN2 
monomers were simply added directly to a freshly cleaved atomically 
flat mica surface (Fig. 3A and movie S1), HS-AFM found a wide 
distribution of arcs as well as rings of subunits with sizes ranging 
from 1 to 16 subunits (16 subunits corresponding to the complete 
ring) (Fig. 3C, green). In these experiments, only 7% of the assemblies 
overall formed complete rings (16 subunits). In contrast, on lipid 
bilayers (Fig. 3B), the overwhelming majority of membrane-bound 
oligomers formed complete rings (Fig. 3C, magenta). The complete 
rings were in total ≥80% of the assemblies found on lipid bilayers, 
uncompleted rings (arcs) only occurring on the competing borders 
of adjacent patches of hexagonal rings. While the assemblies displayed 
no long-range order on the mica, on the membrane, the rings ar-
ranged hexagonally (Fig. 3B). From this, we concluded that PFN2 
existed as monomers or small-sized oligomers in solution and that 
their direct adsorption to the mica, where lateral diffusion is hind-
ered, did not allow the protein to form complete rings. In contrast, 
when incubated on a membrane, where lateral two-dimensional 
(2D) diffusion is allowed, PFN2 formed stable rings 24 nm in diameter, 
which furthermore assembled into a hexagonal, i.e., the densest, 
molecular packing (Fig. 3C, inset, and movie S2). To further explore 
whether the oligomers observed using HS-AFM were membrane- 
bound PFN2 pre-pores, we performed a force-sweep experiment to 
clear them from the area of observation: The distribution of oligomeric 
assemblies recovered by diffusion within ~10 s after minimizing the 
force applied to the tip, as expected for membrane-associated struc-
tures (Fig. 3D and movie S3). The occasional observation of incom-
plete PFN2 rings on membranes allows the determination of subunit 
Fig. 2. The P2 domain  hairpin is responsible for membrane binding. (A and 
B) Atomic structure of P2 domain showing pseudo-threefold symmetry repeat colored 
blue, pink, and green. Disulfide bonds linking the  strands are labeled in yellow; the 
-hairpin region is marked with a dashed rectangular box. (C) Superimposition of the 
P2 cryo-EM structure (pre-pore model in green and pore model in purple) and 10 crystallo-
graphically distinct copies of the P2 domain (gray). (D and E) Ultracentrifugation- 
based liposome-binding assays of mPFN2 P2 domain; the liposomes contained 
different concentrations of phosphatidylserine (PS) (D) or negatively charged or neutral 
lipids (E). PC, phosphatidylcholine; PE, phosphatidylethanolamine; CL, cardiolipin; 
SM, sphingomyelin; 30E, 30% of E. coli total lipid extract; 40E, 40% of E. coli total 
lipid extract; LPSS, LPS from S. enterica; LPSE, LPS from E. coli. (F) Ultracentrifugation- 
based liposome-binding assays of mPFN2 P2 domain and P2hairpin truncation 
mutant. Green underlines in (E) and (F) indicate the same liposome composition 
with 50% PC/10% PS/40% E. coli total lipid extract. WT, wild type.
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association and dissociation rates, which were similar: 2.4 subunits·s−1 
and 2.3 subunits·s−1, respectively (Fig. 3E).
The dimensions of the pre-pores measured by AFM [~24 nm outer 
diameter with an upper protrusion (top ring) diameter of ~11 nm; 
Fig. 3C, inset] provide further evidence of the orientation of the 
pre-pore oligomer with respect to the membrane. Consulting the 
PFN2 pre-pore structure, an upper protrusion of ~11 nm diameter 
arises when the TMH regions of the MACPF domain are accessible 
to the HS-AFM tip, orienting the P2 domain  hairpin toward the 
lipid bilayer. If the oligomer were bound the other way up, then the 
diameter of the upper surface of the membrane-bound pre-pore 
would be ~15 nm. Thus, HS-AFM shows dynamic pre-pore forma-
tion as a lateral diffusion-dependent process leading to ring-shaped 
assemblies with ~24 nm outer diameter. The pre-pores can adhere 
to the bilayer via their -hairpin exposing face, in agreement with 
the structural charge distribution of the pre-pore (fig. S3D) and lipid- 
binding experiments (Fig. 2). In this orientation, the membrane- 
inserting regions of the MACPF domain would point directly away 
from the targeted membrane.
Acidic pH triggers PFN2 pre-pore–to–pore transition
We next examined the membrane-perforating activity of mPFN2 using 
several complementary approaches. First, a sulforhodamine B–based 
leakage assay revealed PFN2 concentration–dependent dye leakage 
from pre-formed liposomes (PC/PS/E. coli total lipid extracts, 5:1:4) 
at pH 5.5, whereas no dye leakage was observed at pH 7.5 (Fig. 4A 
and fig. S5, A and B). At acidic pH 4.0 and 3.0, mPFN2 showed in-
creased dye leakage compared to that at pH 5.5 (Fig. 4B and fig. S5C). 
Furthermore, negative-stain electron microscopy revealed that most 
of the membrane-bound mPFN2 oligomers were pre-pores with oc-
casional pores at pH 5.5 (Fig. 4C and figs. S5D, red box, and S6A). 
Side views of these pre-pores displayed similar profiles to those of 
Fig. 3. HS-AFM of MPFN2 pre-pore structure and assembly. (A) HS-AFM high-resolution image of mPFN2 on mica. Most of the mPFN2 oligomers are incomplete crescent- 
shaped assemblies, likely due to restricted lateral diffusion on mica necessary for full assembly of rings. The individual subunits can be distinguished (inset image). The 
inset section profile shows that pre-pore rings have a height of ~8.5 nm, which is consistent with the cryo-EM pre-pore model. (B) HS-AFM image of mPFN2 on an E. coli 
lipid bilayer. Essentially all mPFN2 oligomers are complete rings that assemble into a close-packed hexagonal lattice. (C) Histogram analysis of mPFN2 assembly on mica 
and on an E. coli lipid bilayer. On mica, mPFN2 displays a wide range of arc angles from one subunit to a full ring. On the lipid bilayer, ≥80% of mPFN2 molecules form 
complete ring assemblies, with a top ring diameter of 11.2 ± 0.9 nm and an outer diameter of 23.8 ± 1.2 nm (inset). (D) HS-AFM images of mPFN2 oligomers on an E. coli 
lipid bilayer (t = 0 s and t = 142 s) exposed to HS-AFM tip force induced removal (t = 54 s), giving access to an empty bilayer (t = 82 s) followed by assembly recovery (t = 105 s), 
in agreement with bilayer surface–associated pre-pores. (E) HS-AFM images (frame acquisition speed: 500 ms) and histogram analysis of mPFN2 subunit association (2.4 s−1) 
and dissociation (2.3 s−1) rates. Around 10 association/dissociation events were measured for identical mPFN2 oligomers in a single time frame, and more than 15 oligomers 
were recorded (total events, both >150). Histograms of association and dissociation rates were fit to a single exponential decay function. Full rings, where all subunits 
have neighbors on both sides, are stable over extended periods of time.
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the cryo-EM structure, confirming that PFN2 adheres to the lipid 
bilayer via its P2  hairpin and with the membrane-inserting re-
gions of the MACPF domain facing in the pre-pore in the opposite 
direction (Figs. 1 and 4C). In contrast, multiple mPFN2 pores were 
formed on liposomes containing 40% E. coli total extract at pH 4.0, 
resulting in the clustering of the liposomes so that it was not easy to 
identify the individual mPFN2 oligomers (fig. S6C). Thus, we incu-
bated mPFN2 with liposomes containing sphigomyelin (fig. S6, B 
and D), which showed much less binding with the P2 domain. The 
distributed pore-forming mPFN2 oligomers on the liposome at 
pH4.0 showed an enlarged lumen compared to that of the pre-pore 
(Fig. 4D, compared to C, and fig. S6D). Side views of membrane- 
inserted pores were very different from those of pre-pores, with ob-
vious transmembrane channels and standing significantly taller than 
the pre-pore form (110 Å compared to 85 Å) (Fig. 4D).
Third, giant unilamellar vesicle (GUV) imaging in the presence 
of fluorescent dextrans (FDs) of increasing sizes showed that the 
PFN2 ectodomain forms pores, allowing almost complete equili-
bration of 4-kDa dextran (~2.8 nm diameter) and 10-kDa dextran 
(~4.6-nm diameter) and no leakage of 70-kDa dextran (~12 nm 
diameter) into the GUV interior (Fig. 4, E and F). The size-dependent 
passage of FDs through PFN2 pores matches what was previously 
observed with similar experiments on perforin-1, which forms 
oligomers of similar size to PFN2 (4). Fourth, channel conductance 
measurements revealed the formation of discrete pores in mem-
branes targeted by PFN2 with a range of sizes and conductance 
noise—in line with observations made for perforin-1 pores (4)—but 
with a consistent pattern of pores opening in discrete steps due to a 
defined pre-pore–to–pore transition (Fig. 4G).
Last, we performed direct pre-pore–to–pore activation experi-
ments via HS-AFM when coupled to a buffer exchange system (20). 
Upon exposure to a low pH shock, the PFN2 pre-pore rings began 
to form pores after 14 s and all ~70 being imaged transited to the 
pore state within 3 s (Fig. 5 and movie S4). The resulting structures 
were higher (raised by ~4 nm) compared to the pre-pore state, in 
agreement with the pores imaged by negative-stain electron micros-
copy (Fig. 4D).
Overall, these results show that acidic pH triggers pre-pore–to–
pore transformation, which is achieved by a 180° rotation of the 
MACPF and P2 domains with respect to each other so that membrane 
insertion can occur. This would require at least two significant con-
formational rearrangements: Rotation at the MACPF/P2 domain 
interface and unfurling of the TMHs into  hairpins. To test this 
hypothesis, we made use of two PFN2 disulfide bond mutants, follow-
ing a strategy successfully implemented with perforin-1 and other 
MACPF/CDC family members (2). PFN2G568C/T594C locks the CTT 
to the P2 domain, and PFN2K251C/G286C prevents the deployment of 
the TMH2 region from the MACPF domain (fig. S7, A to C): Neither 
PFN2G568C/T594C nor PFN2K251C/G286C was active to form pores on 
liposomes when the engineered disulfide bridge was present at pH 5.5 
Fig. 4. Pore-forming activity of mPFN2. Liposome leakage assay of purified mPFN2 protein incubated with liposomes containing 50% PC, 10% PS, and 40% E. coli total 
lipid extract. Liposome leakage was monitored by measuring fluorescence of released sulforhodamine B, and 0.2% SDS treatment was used as a positive control of 100% 
dye leakage. (A) Liposome leakage was dependent on mPFN2 concentration. (B) Increased sulforhodamine B release was observed with liposomes preformed at acidic 
pH (4.0 and 3.0) compared to at pH 5.5. Final leakage of sulforhodamine B is expressed as mean ± SD from three technical replicates, as shown in fig. S4 (B and C). All data 
shown are representative of three independent experiments. (C) Representative negative-stain micrograph and 2D class averages of mPFN2 incubated with liposomes 
containing 50% PC, 10% PS, and 40% E. coli total lipid extract at pH 5.5, with a dashed red box showing a side view of a membrane-bound pre-pore. Scale bar, 50 nm. 
(D) Representative negative-stain micrograph and 2D class averages of mPFN2 incubated with liposomes containing 40% PC, 30% PE, and 30% SM at pH 4.0; the lumen 
of the pores is much bigger than that of the pre-pores shown in (C). A dashed red box highlights a side view of a pore. Scale bar, 50 nm. (E) Permeabilization of GUVs 
composed of POPC:POPS:E. coli lipid extract (80:10:10; w/w) (+ rhodamine-DHPE; red channel) by addition of PFN2 (0.1 mg/ml) and fluorescent dextrans (FDs) at pH 5.7, 
after 60-min (FD4, 4 kDa) or 120-min (FD10 and FD70, 10 and 70 kDa) incubation. Scale bar, 20 m. (F) Quantification of GUV permeabilization from conditions shown and 
described in (E). CON denotes control sample without addition of PFN2. (G) Pore formation of PFN2 on planar lipid bilayers composed of POPC:POPS:E. coli lipid extract 
(70:10:20; w/w) at 10 mM MES and 500 mM NaCl (pH 5.5). The red numbers on the graph correspond to the three traces shown (right). The loss of pore conductance in 
traces 2 and 3 is likely due to the loss of pore structures from membranes.
 o
n
 February 3, 2020
http://advances.sciencem
ag.org/
D
ow
nloaded from
 
Ni et al., Sci. Adv. 2020; 6 : eaax8286     29 January 2020
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
6 of 12
(fig. S7, D to F), although pre-pore assembly was observed in both 
cases as with the wild-type (WT) protein (Fig. 4C and fig. S7, D and 
E). Addition of reducing reagent activated both mutants by cleaving 
the disulfide bond, allowing detachment of the MACPF domain 
from the P2 domain and the unfurling of the TMH2 region: 1 mM 
dithiothreitol (DTT) reduced PFN2K251C/G286C, but 10 mM DTT was 
necessary for the same effect on PFN2G568C/T594C, most likely because 
these cysteines are buried in the MACPF domain/P2 domain interface 
(fig. S7G). Together, these results demonstrate the need to release 
the interdomain lock between the MACPF domain and P2 domain 
to allow a 180° rotation, and then the unfurling of the MACPF do-
main TMHs, for pore formation to occur.
Cryo-EM structure of the PFN2 pore
To generate a sample of pores for structure determination, we pre-
pared pre-pores at pH 5.5 as for the structure reported above and 
then lowered the pH to 3.6-4.0 in the presence of Cymal-6 (fig. S8, 
A and B). The cryo-EM structure of the pore was determined to an 
overall resolution of ~5 Å (Fig. 6, A and B; fig. S8, C and D; and table 
S1). The resolution for the central MACPF region of the cryo-EM 
map is ~4.5 Å, whereas the peripheral regions have lower resolu-
tions ranging from 5.0 to 9.2 Å (fig. S8, C and D). We were able to 
construct a model of the pore fitted to its cryo-EM density guided 
by the distinctive features of each PFN2 domain and their connec-
tivity and the conserved two glycans visible in both structures. We 
were unable to resolve the CTT domain due to the absence of den-
sity for the CTT in the PFN2 pore map, suggesting that it may have 
become intrinsically disordered on pore formation. Our structure 
confirms the rotation between the MACPF and P2 domains by 180° 
and reveals other conformational changes accompanying membrane 
insertion including the deployment of TMH1 and TMH2 to generate 
a 64-stranded -barrel (Fig. 6, B to D). In the pore form, the MACPF 
domain has rotated with respect to the P2 domain by ~180° when 
viewed from the side and by ~90° when viewed from above (looking 
down toward the membrane surface) compared to its position in 
the pre-pore, resulting in a compound screw rotation (Fig. 6D). The 
pore-forming oligomer structure is entirely consistent with the pores 
imaged directly on liposome membranes and is 206 Å in diameter 
and 140 Å tall from the top of the MACPF domain to the tip of the 
-barrel (Fig. 6, A and B) (1, 2, 5, 21, 22).
DISCUSSION
Our structures of mPFN2 pre-pore and pore forms provide intrigu-
ing insights into its mechanism of pore formation. Depending on 
whether PFN2 is released to the phagosome lumen by proteolysis 
(12), two models can be proposed for the mechanism underlining pore 
formation by PFN2 (Fig. 6E). In model 1, monomeric PFN2 is released 
into the phagosome lumen after its cleavage from the phagosome 
membrane, binding to a target bacterial surface and oligomerizing 
upon it into a pre-pore assembly. Upon activation by acidification 
of the phagosome, the MACPF domain rotates by 180° with respect 
to the membrane-bound P2 domain, followed by the unfurling of 
its TMHs (Fig. 6E, left, model 1). If considered as a rigid body move-
ment, the steric clash between MACPF domains will not allow rings 
of subunits to make this transition intact, and we hypothesize that 
pore formation begins with the opening of the pre-pore oligomer 
between two subunits, allowing the conversion to the pore state to 
begin. In an alternative model (Fig. 6E, right, model 2), PFN2 remains 
membrane-anchored in its pre-pore form and close approach of the 
phagosome membrane and bacterium is essential for the binding of 
the pre-pore to the bacterial surface via a 180° rotation of the P2 
domain. Subsequently, the MACPF domain TMHs would be un-
furled and inserted into the bacterial surface; in this model, the CTT 
would act as an interdomain lock by interacting with an adjacent 
subunit’s P2 domain  hairpin, as in the pre-pore structure. But 
upon pore formation on a bacterial membrane, the CTT might then 
become a flexible linker between the phagosome and bacterial mem-
branes. However, in this model, the oligomerization of PFN2 into a 
pre-pore occurs before membrane binding, whereas in all other 
MACPF/CDC proteins membrane binding precedes oligomerization. 
In addition, rotation of the P2 domain with respect to the MACPF, 
as in model 2, also results in a clash between subunits. Which model 
outlined is more correct—i.e., whether the P2 domain binds the target 
membrane before or after pre-pore formation—and the exact confor-
mational pathway taken in each case will require further experimen-
tation and, most likely, a combination of high-resolution real-time 
AFM imaging with structural characterization of pore formation 
intermediates.
CONCLUSION
Together, we have used cryo-EM to determine structures for the 
pre-pore and pore forms of PFN2, x-ray crystallography to deter-
mine multiple conformations of its membrane-binding P2 domain, 
high-speed AFM to image pre-pore and pore formation in real time, 
functional assays of PFN2 based on fluorescence imaging and spectros-
copy and conductance measurements, and site-directed mutagenesis 
to test hypotheses arising from the structural and dynamic data. 
The outstanding insight from our study is that the TMH membrane- 
inserting regions of the pore-forming MACPF domain are oriented 
Fig. 5. Pre-pore–to–pore transition observed by HS-AFM. (A) HS-AFM image 
(left) of mPFN2 on an E. coli lipid bilayer as in Fig. 3B then (middle and right) images 
of the same area as the pH is reduced to 3.6 to 4.0. An increase in oligomeric height 
results in a sharpening of the AFM image as the oligomers come more closely into 
contact with the cantilever tip. (B) Height profile of the transit shown with a white 
dashed line in (A) (middle), confirming an increase in oligomeric height above the 
targeted lipid bilayer on acid-triggered pore formation. The gray, red, and black 
lines indicate the height profile of pre-pore, mid-transition, and pore states, indi-
vidually, along the path defined by the dashed line in (A). The red arrowheads in (A) 
and (B) show the same position.
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in the opposite direction to the membrane-binding region of the P2 
domain in the PFN2 pre-pore. In all other pore-forming MACPF/CDC 
proteins, the membrane-binding domain and TMHs are oriented in 
the same direction in their membrane-bound pre-pore states (23, 24). 
Domain reorientation during pore formation is not unique to the PFN2 
transition: In the aerolysin pore-forming protein family, the pore- 
forming domain refolds inward on pore formation (25, 26). But by 
contrast—and uniquely for MACPF/CDC proteins studied in molec-
ular detail—PFN2 wholly reorients the relationship between its pore- 
forming domain and membrane-binding domains via a circumferential 
swing before deployment of its membrane-inserting TMHs. This ar-
rangement may enable stringent control of pore formation such that 
formation occurs only upon phagosome acidification, for more ef-
fective killing of engulfed bacteria. We suggest that the three domains 
involved—the membrane-bound P2 domain, the EGF module at the 
hinge point, and the pore-forming MACPF domain— are specifically 
selected to enable this transition. The P2 domain helps to stabilize the 
pre-pore state by swapping between monomers and enables PFN2 
to bind its targeted membrane. The EGF module provides a focal point 
for the rotation to occur, and the MACPF domain is adapted for the 
well-established helix-to-sheet transition accompanying MACPF/
CDC pore formation (27) and for packing stably into oligomers in the 
two different orientations found in the pre-pore and pore.
The other domains out of which PFN2 is built are found in similar 
forms in many other MACPF/CDC family proteins, such as perforin-1 
and components of the complement MAC as well as non–pore- 
forming family members like astrotactin-2 (3, 28–30), and a related 
set of domains is found in the bacterial CDCs (31). So why are the 
domains arranged with the MACPF and P2 domains pointing in 
opposite directions in PFN2? Given the pH activation of pore forma-
tion, we suggest that this pre-pore arrangement holds PFN2 in an in-
active state until the correct endosomal pH is achieved to facilitate 
effective killing of bacteria by membrane perforation. Given the an-
tiquity of the PFN2 gene [see above and (7, 9)], we further suggest that 
the configuration of all other MACPF/CDC proteins described with 
pore-forming and membrane-binding regions pointing in the same 
direction in the pre-pore state is an adaptation of the opposite config-
uration found in PFN2. This may have been facilitated by the loss of 
the CTT from ancestral PFN2 on duplication to initiate the evolution 
of perforin-1, because it is not found in other family members.
MATERIALS AND METHODS
Construct preparation, protein expression, and purification
The P2 domain of murine PFN2 (mPFN2; UniProt: A1L314) was 
cloned into the pHLsec vector (32) with Age I and Kpn I restriction 
Fig. 6. Cryo-EM structure of mPFN2 pore. (A and B) Top view (A) and side view (B) of mPFN2 model fitted in the cryo-EM map. (C) A single subunit segment of mPFN2 
pore map (gray) with model fitted into the density viewed from the side. Domains were color-coded as in Fig. 1. (D) Superposition of mPFN2 monomer in the pre-pore 
form (gray) and the pore conformation (green), showing a 180° rotation of the MACPF domain viewed from the side and a 90° rotation from the above. The two TMHs 
were highlighted in red in both conformations, and the magenta asterisks indicate the same region in the two conformational states. (E) Two proposed models illustrating 
the conformational changes during the pre-pore–to–pore transition of mPFN2. In model 1, mPFN2 is released to the phagosome lumen after the cleavage from its trans-
membrane domain, and it assembles as a pre-pore at pH 5.5 on the bacterial membrane (Pre-pore I); further acidification (pH 4.0) of the phagosome triggers a ~180° re-
orientation of the MACPF domain leading to the two TMHs (red) facing the membrane (Pre-pore II), and then the helical TMH regions unfold to form a -stranded barrel, 
which inserts into the membrane in pore formation (Pore). In model 2, mPFN2 assembles as a pre-pore on the phagosome membrane (at pH 5.5) while still tethered on 
the phagosome membrane via its transmembrane region; further acidification (pH 4.0) triggers a ~180° reorientation of the P2 domain, resulting in binding to a nearby 
bacterium (Pre-pore II) and subsequent pore formation in its surface membrane (Pore). Domains of mPFN2 in the schematic were color-coded as in Fig. 1: TMHs colored 
in red within the MACPF domain (blue), P2 in green, and CTT in orange; the transmembrane domain is shown as a light blue stick, and the cytosolic tail is shown as a gray 
line. For the pore conformation, only MACPF and P2 domains are shown, because the CTT domain is not resolved in the pore structure.
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cutting sites, resulting in a signal peptide in the N terminus of the 
proteins and a KTHHHHH tag in the C terminus. The signal peptide 
was cleaved during protein secretion into the medium, leaving an addi-
tional three residues Glu-Thr-Gly at the N terminus of the proteins. 
Full-length mPFN2 ectodomain (residues 20 to 652) was cloned 
into pHLsec-1D4, replacing the His6 tag with a rhodopsin 1D4 tag 
(33). Overlapping polymerase chain reaction was performed to in-
troduce site-directed mutagenesis.
All the proteins in this study were produced recombinantly 
from mammalian human embryonic kidney (HEK) 293T cells or 
HEK293S cells using a transient transfection and expression protocol 
as described (17, 30). To express the P2 domain in HEK293T cells 
for crystallization, 6 mg of purified DNA vector was transfected 
into 3 liters of HEK293T cells in the presence of the glycosylation 
inhibitor kifunensine (final concentration, 5 M) with 12 mg of 
polyethylenimine. The transfected cells were harvested 4 to 5 days 
after transfection. Three liters of medium containing secreted proteins 
was harvested by centrifugation at 5000g for 45 min to remove the 
cell debris, filtered through a 0.22-m filtration membrane, and 
dialyzed against 10× volume of phosphate-buffered saline [10 mM 
phosphate (pH 7.5) and 300 mM NaCl] overnight at 4°C. The dia-
lyzed medium was supplemented with 20 mM imidazole and loaded 
onto a HisTrap HP (GE Healthcare) column overnight at room 
temperature and eluted with a linear imidazole gradient (20 to 
500 mM imidazole) in 25 mM tris (pH 7.5) and 500 mM NaCl. The 
eluted proteins were pooled together and deglycosylated with Endo 
F1 overnight at 4°C, concentrated, and applied to a size-exclusion 
chromatography column (Superdex 75 16/600), and a peak corre-
sponding to the monomeric species was concentrated to about 
12 mg/ml in 10 mM Hepes (pH 7.5) and 150 mM NaCl. The pro-
teins were flash-frozen in liquid nitrogen and stored in −80°C until 
further use.
Ectodomain of mPFN2 was purified from the medium using anti- 
1D4 antibody–coupled agarose resin. Six liters of mammalian ex-
pression medium with secreted mPFN2 was concentrated to 500 ml 
using a QuikStand device (Watson, Marlow) with a 10-kDa cutoff 
membrane, filtered, and incubated with anti-1D4 monoclonal anti-
body–coated resin preequilibrated in 25 mM tris (pH 7.5) and 500 mM 
NaCl buffer overnight at 4°C. The agarose resin with mPFN2 bound 
was then washed with 25 mM tris (pH 7.5) and 500 mM NaCl buffer 
before being eluted with 2 ml of 1D4 peptide at a concentration of 
0.5 mg/ml. The sample was concentrated using a 30-kDa centrifugal 
concentrator (Millipore) to about 1.2 mg/ml and flash-frozen in liquid 
nitrogen for storage at −80°C. The mutants of the ectodomain were 
purified in the same way.
Cryo-EM sample preparation and data collection
The mPFN2 ectodomain was incubated with buffer containing 
50 mM citric acid buffer (pH 5.5) and 150 mM NaCl at 0.5 mg/ml 
at 37°C overnight to form pre-pore oligomers, which were further 
purified through size-exclusion chromatography (Superose 6 10/300). 
Fractions corresponding to the homogeneous oligomers were pooled 
together and concentrated to ~0.5 mg/ml. Tween 20 was added to 
the protein solution at a final concentration of 0.01% and incubated 
for 30 min before cryo-EM grids were prepared. The mPFN2 pore 
sample was prepared by lowering the pH of the pre-pore samples to 
pH 3.6 to 4.0 in the presence of 0.056% Cymal-6 (final concentration) 
at room temperature for 30 min. The pH was estimated by large-scale 
mixing of the pre-pore assembly buffer [50 mM citric acid (pH5.5) 
and 150 mM NaCl] with 1 to 1.5× volume of 170 mM citric acid 
(pH3.3) and 150 mM NaCl.
For cryo-EM, 3 l of mPFN2 pre-pore (~0.3 mg/ml) was applied 
to a glow-discharged lacy carbon grid with ultrathin carbon support 
film (Agar, UK), blotted for 3.5 s in 100% humidity at 22°C, and 
flash-frozen in liquid ethane with an FEI Vitrobot Mark IV. The 
mPFN2 pore (~0.12 mg/ml) was frozen in the same way. The mPFN2 
pre-pore grids were imaged using an FEI Polara electron microscope 
operating at 300 kV with semi-automated image acquisition via 
SerialEM. Micrographs were acquired with a Gatan K2 Summit direct 
electron detection camera operated in the counting mode at a cali-
brated magnification of ×48,076 and defocus values ranging from 
−1.0 to −2.5 m. The mPFN2 pore data were collected using a Thermo 
Scientific Glacios operating at 200 kV with a Falcon III camera in 
linear mode. The details of data collection parameters are summa-
rized in table S1.
Cryo-EM image processing
For cryo-EM data of mPFN2 pre-pore, beam-induced motion cor-
rection was performed using MotionCor2 (34) to generate dose- 
weighted micrographs from all frames. The contrast transfer function 
was estimated using Gctf (35). XMIPP (36) was used for automatic 
particle picking, and the particles were further manually inspected. 
In total, 246,755 particles were extracted and initially binned 2×. 
After several rounds of reference-free 2D classification in RELION 
(37), good class averages representing the C16 symmetry were selected 
and further processed. About 5000 particles were used to generate 
an ab initio model in cryoSPARC (38), and the resulting initial 
model was used for 3D classification in RELION with C16 symmetry 
imposed. Particles from two classes (41,693 particles) with similar 
density maps were selected and reextracted at full size for further 
3D refinement, resulting in a map with overall resolution of ~3.5 Å. 
The overall B factor was automatically determined using the RELION 
PostProcess tool, with an estimated B-factor applied of −144 Å2. 
The global resolution was estimated by the gold-standard Fourier 
shell correlation (FSC) = 0.143 criterion, with a soft mask applied 
around the protein density. The local resolution was estimated using 
RELION and presented in Chimera (39).
The dataset of mPFN2 pores was processed with similar procedures. 
In brief, automated particle picking was performed using Gautomatch 
(www.mrc-lmb.cam. ac.uk/kzhang/Gautomatch). A total of 44,046 
particles contained in good 2D classes of all side and top views of 
C16 symmetry pores were selected after three rounds of 2D classifica-
tion in RELION. An ab initio model generated with these particles 
in cryoSPARC was used for 3D classification in RELION without 
applying symmetry. The best class (24,936 particles) was further re-
fined with C16 symmetry in RELION, resulting in a map with local 
resolution ranging from 4.1 to 9.2 Å. All subsequent post-processing 
steps were performed in the same way as described above for the 
pre-pore dataset.
Model building into the cryo-EM reconstruction, refinement, 
and structure visualization
Phyre2 (40) was used to generate a homology model of the MACPF 
domain of mPFN2, using the perforin-1 crystal structure as the 
template [Protein Data Bank (PDB) entry code: 3NSJ]. The MACPF 
homology model was first fitted into the density map and manually 
rebuilt. The P2 domain crystal structure was manually fitted into the 
map, with major adjustment in the extended  hairpin. The remaining 
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density map was manually traced. Real-space refinement was per-
formed in Coot (41) and phenix.real_space_refine (42) using the 
B-factor sharpened density map. Secondary structure restraints from 
the x-ray crystallography model were applied when fitting the P2 
domain into the cryo-EM map. A region of density with a local reso-
lution of ~5 Å was modeled as a helix (residues L633-H643), which 
was also predicted from its secondary structure analysis. The pre-
sented map was filtered by its local resolution. The figures were pre-
pared using Chimera (39) and PyMOL (The PyMOL Molecular 
Graphics System version 2.0, Schrödinger LLC).
To generate a model of the PFN2 pore, we first fitted the 
MACPF-EGF region (residues 31 to 371) minus TMH1 and TMH2 
into the equivalent region of the pore map using Chimera (39). 
This also allowed us to confirm the correct hand for the map. We 
used the program iMODFIT (43) to then refine the MACPF-EGF 
domain structure into the density, whereby normal modes analy-
sis is used to facilitate flexible fitting. This led to a straightening 
of the MACPF domain central  sheet in line with the deploy-
ment of the TMH1 and TMH2 regions. We then fitted the P2 
domain, making use of all 11 structures to hand (10 crystals and 
1 cryo-EM from the pre-pore). We found that the best fit was for 
chain B of the P1 crystal form and so used that in rigid body fit-
ting into its density within the pore map. This process placed the 
C terminus of the EGF and the N terminus of the P2 domain 
close enough in space that the connectivity of the model could be 
restored manually in Coot (41). A further round of iMODFIT 
refinement was followed by the manual construction of two  hair-
pins for TMH1 and TMH2 using Coot (41) constrained by the 
alignment of residue Asn269 to it attached glycan density, followed 
by construction of a full 16-mer pore and refinement using phenix.
real_space_refine (42) in isolation and incorporated in the Namdi-
nator online server (44, 45), until convergence was achieved. Nam-
dinator runs made use of implicit solvent in the latter cycles of 
refinement.
Structural phylogeny construction
Superimposition of homologous protein structures was performed 
using SHP (46) as previously reported (47). The phylogenetic tree 
was calculated using a pairwise evolutionary distance matrix deter-
mined from the superimposed domains. The tree representation was 
generated using the programs FITCH and DRAWTREE as part of 
the PHYLIP package (48).
Protein crystallization, x-ray diffraction data collection, 
and structure determination
Crystallization screening was carried out by sitting-drop vapor- 
diffusion methods in CrystalQuick 96-well plates by mixing 100 nl 
of protein solution with 100 nl of reservoir and equilibrating against 
95 l of reservoir at 20°C. Deglycosylated P2 domain was concen-
trated to 10 to 15 mg/ml and crystallized in 0.1 M MES (pH 6.0) and 
10% PEG-6000 (polyethylene glycol, molecular weight 6000) with 
50 nl of additives (0.02 M l-cysteine stock). The crystals appeared 
after 2 weeks and grew to full size within 1 month. The crystals were 
harvested with 25% glycerol as the cryoprotectant in liquid nitrogen. 
The crystal diffraction data were collected on I24 and I03 beamlines 
at Diamond Light Source (Didcot, UK). For experimental phasing, 
the crystals were soaked with concentrated gold cyanide for 1 hour. 
The derivative dataset was collected at a wavelength of 1.04 Å (see 
table S2 for details of data collection).
A gold-derivative single anomalous dispersion (Au-SAD) analy-
sis was first performed in HKL2map (49) to identify the heavy atom 
positions. The resulting heavy-atom coordinates were subsequently 
used together with a native dataset to carry out single isomorphous 
replacement anomalous scattering analysis in phenix.autosol (50). 
The resulting electron density was used in phenix.autobuild (51) to 
generate a partial model. The subsequent model building and re-
finement were carried out in Coot (41) and phenix.refine (42). The 
final refined model contains residues from Phe376 to Ile579, with one 
missing loop between Val538 and Pro549. The other crystal form was 
phased by molecular replacement using the refined P2 domain model 
with -hairpin truncation. The electron density representing the  
hairpin was clearly visible after rigid-body refinement. The subse-
quent model building and refinement were carried out in Coot and 
phenix.refine (41, 42).
Negative-stain electron microscopy
Wild-type PFN2 ectodomain and the disulfide-linked mutants were 
incubated with liposomes at room temperature for 30 min. A 3-l 
mixture was applied to a glow-discharged copper grid covered with 
carbon film (Electron Microscopy Sciences), washed twice with 
dH2O, stained with 0.75% uranyl formate or 2% uranyl acetate for 
1 min, and blotted dry with filter paper. Negative-stained images 
were collected using FEI Tecnai T12 microscopes at a nominal mag-
nification of ×67,000, with a calibrated pixel size of 1.7 Å. The par-
ticles were manually picked and extracted in EMAN2 (52), and the 
sub sequent image analysis was carried out with Imagic (53).
Liposome sedimentation assay and sulforhodamine B 
liposome leakage assay
POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine), 
POPS (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoserine), POPE 
(1-palmitoyl- 2-oleoyl-sn-glycero-3-phosphoethanolamine), cardio-
lipin, sphingomyelin (brain, Porcine), and E. coli total lipid extract 
were purchased from Avanti Polar Lipids Inc. LPSs from S. enterica 
(L1887) and E. coli (L2018) were purchased from Sigma. Liposomes 
with the compositions indicated were prepared following standard 
protocols. Briefly, a total of 1 mg of lipids dissolved in chloroform was 
mixed and dried in a clean Pyrex tube overnight by desiccation in a 
desiccator attached to a VARIO-SP diaphragm pump (Vacuubrand). 
The lipid film was subsequently hydrated by adding 0.5 ml of solubi-
lization buffer [20 mM Hepes (pH 7.5) and 150 mM NaCl] followed 
by vigorous vortexing and 5 to 10 freeze-thaw cycles, and the resulting 
mixture was then extruded through 100-nm polycarbonate mem-
brane (Whatman) 11 times using an extruder (Avanti Polar Lipids 
Inc.). To prepare liposomes with LPSs incorporated, LPS dissolved 
in buffer [20 mM Hepes (pH 7.5) and 150 mM NaCl] was added into 
the solubilization buffer before freeze-thaw cycles and extrusion. 
The liposomes were stored at 4°C and used within 2 days. To perform 
liposome sedimentation assays, 5 g of mPFN2 protein (P2 domain; 
P2hairpin protein; ectodomain or ectodomainCTT) was incubated 
with 50 l of liposome (2 mg/ml) for 1 hour at 37°C. The proteins 
incubated with buffer only [20 mM Hepes (pH 7.5) and 150 mM 
NaCl] served as negative controls. The protein buffer/liposome 
mixtures were then centrifuged at 67,000 rpm in an ultracentrifuge 
(Optima TL with TLA100.4 rotor) for 20 min at 10°C. The super-
natant was collected to examine proteins unbound to the lipo-
some. The pellets were resuspended in solubilization buffer with the 
same volume as the supernatant. Equal amounts of supernatant 
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and pellet were loaded for SDS–polyacrylamide gel electrophoresis 
analysis. Each liposome sedimentation assay was performed at least 
three times.
Sulforhodamine B liposome leakage assays were conducted as 
described (54). Briefly, the dried lipid mixtures as described above 
were rehydrated with 0.5 ml of different solubilization buffers [20 mM 
Hepes (pH 7.5)/50 mM citric (pH 5.5)/50 mM citric (pH 4.0)/50 mM 
citric (pH 3.0) supplemented with 150 mM NaCl and 50 mM sulfor-
hodamine B]. After extrusion, the sulforhodamine B dye outside the 
liposome was removed by buffer exchange using a disposable PD 10 
desalting column (GE Healthcare). The buffer exchange was per-
formed twice to remove the residual sulforhodamine B outside the 
liposome. To perform the liposome leakage assay, the dye-encapsulated 
liposome was first diluted 50 times. The fluorescence of sulfor-
hodamine B was measured with excitation wavelength of 585 nm 
and emission wavelength of 610 nm. The emission fluorescence before 
adding the proteins was used as Ft0, 4 l of protein at different con-
centrations was then added to 50 l of liposomes, and the emission 
fluorescence was continuously measured as Ftn every 30 s for 60 min. 
Addition of buffer to the liposome was treated as a negative control 
to examine the stability of the liposomes overtime, while addition of 
4 l of 2.5% SDS to completely release the sulforhodamine B from 
the liposomes was treated as a positive control. The final emission 
fluorescence from the positive control was measured as Ft100. The 
percentage of liposome leakage is defined as follows: Leakage (%) = 
(Ftn – Ft0)/(Ft100 – Ft0) × 100. Each leakage assay was performed at 
least three times.
Preparation and imaging of GUVs
GUVs were prepared by the electroformation method (55), as 
described (56). Lipid mixtures [POPC:POPS:E. coli total lipid ex-
tract (Avanti Polar Lipids) = 80:10:10 (w/w)] were dissolved in 
chloroform to a final concentration of 5 mg/ml. Rhodamine-DHPE 
(Lissamine rhodamine B 1,2-dihexadecanoyl-sn-glycero-3- 
phosphoethanolamine, triethylammonium salt) was added to fluo-
rescently label the membranes. Six microliters of the lipid mixture 
was spread on the conductive side of an indium tin oxide (ITO)  slide 
and dried under vacuum. Electroformation was carried out in 
sucrose solution [300 mM sucrose and 1 mM MES (pH 5.7)] be-
tween two conductive ITO slides (Vesicle Prep Pro, Nanion Technologies, 
Germany) under the following conditions: initial increase of amplitude 
from 0 to 3 V with 5-Hz frequency for 30 min, followed by 3 hours 
of constant amplitude of 3 V and frequency of 5 Hz, and ending 
with decreasing frequency from 5 to 0 Hz at a constant ampli-
tude of 3 V at 37°C. GUVs were sedimented by first adding glu-
cose solution [300 mM glucose and 1 mM MES (pH 5.7)], next buffer 
on top [10 mM MES and 150 mM NaCl (pH 5.7)], and GUVs 
were left to sediment overnight. All solutions used for GUV prepa-
ration and experiments were isoosmolar (Osmomat 3000, Gonotec 
GmbH, Germany).
GUVs were mixed with FDs of 4, 10, or 70 kDa (final concen-
tration of 1 mg/ml) and PFN2 (final concentration of 0.1 mg/ml) 
and incubated for 60 or 120 min at room temperature. The buf-
fer was used as a negative control instead of proteins. Images 
were recorded on a DMI6000 CS inverted microscope with TCS 
SP5 laser scanning system (both Leica Microsystems, Germany) 
with a 63× oil immersion objective (numerical aperture, 1.25). 
FDs and rhodamine were excited with 488- and 543-nm lasers, 
and fluorescence emission was detected from 495 to 530 nm and 
from 580 to 630 nm, respectively. Permeabilization of GUVs was 
quantified in ImageJ software. For each experiment, between 50 
and 300 vesicles were quantified in three independent experiments.
Planar lipid bilayer experiments
Planar lipid bilayers were prepared from a mixture POPC:POPS:E. coli 
lipid extract = 70:10:20 (w/w) with a final concentration of lipids 
(5 mg/ml) dissolved in octane. For recording of electrical measure-
ments, multielectrode cavity array chips (Ionera Technologies) were 
used on the integrated chip-based recording setup Orbit mini 
with EDR2 software (Nanion Technologies). Proteins were added 
to the cis side of the bilayer to a final concentration of ~32 ng/l. 
MES (10 mM) and NaCl (500 mM) at pH 5.5 was used as a buffer. 
To promote pore insertion, a voltage from ±50 mV to 200 mV with 
a 20-kHz sampling rate was applied. For the analysis of current, the 
tracing software Clampfit (10.7.0.3.) was used. The noise was quan-
tified as described previously (4). In brief, the SD was determined 
on a short time interval (a few tens of milliseconds) of the individual 
current trace at which the pore was open, and noise was normalized 
by dividing SD with the average current of each trace at which the 
pore was open.
Formation of supported lipid bilayer for HS-AFM
Vesicles were prepared using 100% E. coli total phospholipid extract 
composed of PE:PG:CA:unknown = 57.5:15.1:9.8:17.6 (w/w; Avanti, 
USA). Lipids dissolved in chloroform were dried under argon flux, 
followed by >2-hour incubation in a vacuum desiccator. After that, 
lipids were fully rehydrated with buffer [10 mM Hepes-NaOH (pH 7.5) 
and 200 mM NaCl] for 5 min at room temperature, obtaining lipid 
solution (0.5 mg/ml). Last, the lipid suspension was bath-sonicated 
for 10 min to form vesicles. For mica-supported lipid bilayers, 3 l 
of E. coli lipid solution (0.5 mg/ml) was deposited onto freshly 
cleaved mica (1.5-mm-diameter disc), incubated for 15 min, and 
rinsed thoroughly with buffer [10 mM Hepes-NaOH (pH 7.5), 
200 mM NaCl, and 2 mM CaCl2].
High-speed AFM
The PFN2 assemblies on mica or on lipid bilayers were prepared 
by incubating PFN2 monomers (0.043 mg/ml) for 5 min, either 
directly on mica or on preformed supported lipid bilayers. Then, 
the samples were rinsed and directly imaged by HS-AFM. All im-
ages in this study were acquired using HS-AFM (SS-NEX, RIBM, 
Japan) operated in amplitude modulation mode using optimized 
scan and feedback parameters. Short (8 m) cantilevers (NanoWorld, 
Switzerland) with nominal spring constant of 0.15 N/m, resonance 
frequency of ~0.6 MHz, and a quality factor of ∼1.5  in buffer 
[20 mM Hepes-NaOH (pH 7.5), 200 mM NaCl, and 2 mM CaCl2] 
were used. To study the reversible lateral displacement of pre- 
pores on the membrane, the ratio of set point and free amplitude 
(Aset/Afree) was changed from ~0.95 to ~0.6 and back to ~0.95. 
Under such conditions, the average estimated applied force on the 
HS-AFM tip changes from ~30 to ~200 pN and back to ~30 pN 
(57). To study the pre-pore–to–pore transition, the fluid cell con-
taining ~120 l of buffer [20 mM Hepes-NaOH (pH 7.5), 200 mM 
NaCl, and 2 mM CaCl2] was supplemented with ~15 l of 0.1 M 
HCl (through passive diffusion) to decrease the pH of the buffer 
solution to pH 3.6 to 4.0. The change in pH was estimated by 
large-scale mixing 150 l of 0.1 M HCl into 1.20 ml of the imaging 
buffer.
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